Drugs / N-MONOACETYLCYSTINE
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT05777733 | Mar → Apr 2024 | beta-thalassemia major | Assiut University | Unknown | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT03822637 | Feb 2019 → Feb 2025 | asthma | University of California, San Francisco | Terminated | No outcome recorded Stop: Business |
| Phase 4 | NCT02605824 | Mar 2016 → Dec 2017 | asthma | University of California, San Francisco | Terminated | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT01582555 | Jun 2012 → Jun 2013 | — | Tel-Aviv Sourasky Medical Center | Unknown | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT03241472 Comparator | Feb 2016 → May 2017 | infertility disorder | Assiut University | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | N-MONOACETYLCYSTINE | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297406 ↗ |
| Known as | N-Acetylcystine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01582555 ↗ |
| Modality | Small molecule | — CHEMBL4297406 ↗ |
| Route | Intranasal | “20 mL per nostril given tid daily” NCT01582555 ↗ |